GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChitogenX Inc (XCNQ:CHGX) » Definitions » EV-to-FCF

ChitogenX (XCNQ:CHGX) EV-to-FCF : -9.36 (As of Dec. 15, 2024)


View and export this data going back to 2017. Start your Free Trial

What is ChitogenX EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, ChitogenX's Enterprise Value is C$4.53 Mil. ChitogenX's Free Cash Flow for the trailing twelve months (TTM) ended in Jul. 2024 was C$-0.48 Mil. Therefore, ChitogenX's EV-to-FCF for today is -9.36.

The historical rank and industry rank for ChitogenX's EV-to-FCF or its related term are showing as below:

XCNQ:CHGX' s EV-to-FCF Range Over the Past 10 Years
Min: -10.22   Med: 0   Max: 0
Current: -9.36

XCNQ:CHGX's EV-to-FCF is ranked worse than
100% of 392 companies
in the Biotechnology industry
Industry Median: 8.19 vs XCNQ:CHGX: -9.36

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-15), ChitogenX's stock price is C$0.005. ChitogenX's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2024 was C$-0.022. Therefore, ChitogenX's PE Ratio (TTM) for today is At Loss.


ChitogenX EV-to-FCF Historical Data

The historical data trend for ChitogenX's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChitogenX EV-to-FCF Chart

ChitogenX Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only -5.42 -7.93 -5.37 -5.86 -10.81

ChitogenX Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.86 -8.69 -10.81 -8.29 -11.94

Competitive Comparison of ChitogenX's EV-to-FCF

For the Biotechnology subindustry, ChitogenX's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ChitogenX's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ChitogenX's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where ChitogenX's EV-to-FCF falls into.



ChitogenX EV-to-FCF Calculation

ChitogenX's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=4.532/-0.484
=-9.36

ChitogenX's current Enterprise Value is C$4.53 Mil.
ChitogenX's Free Cash Flow for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ChitogenX  (XCNQ:CHGX) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

ChitogenX's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.005/-0.022
=At Loss

ChitogenX's share price for today is C$0.005.
ChitogenX's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.022.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


ChitogenX EV-to-FCF Related Terms

Thank you for viewing the detailed overview of ChitogenX's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


ChitogenX Business Description

Traded in Other Exchanges
Address
16667 Hymus Boulevard, Kirkland, Montreal, QC, CAN, H9H 4R9
ChitogenX Inc is a clinical-stage biotech company. It operates in one segment, which is the development of novel therapeutic soft tissue repair technologies.
Executives
Luc Mainville Senior Officer

ChitogenX Headlines

From GuruFocus

IMPACTfolio, LLC Buys 3, Sells 2 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 07-06-2022

Top 5 3rd Quarter Trades of Colorado Capital Management, Inc.

By GuruFocus Research GuruFocus Editor 10-19-2022

Top 5 4th Quarter Trades of Colorado Capital Management, Inc.

By GuruFocus Research GuruFocus Editor 01-18-2023